Paper36927176
The evolution of blood-brain barrier permeability changes after stroke and its implications on clinical outcome: A systematic review and meta-analysis.
Bernardo-Castro S and 9 others. Int J Stroke, 2023. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. The evolution of blood-brain barrier permeability changes after stroke and its implications on clinical outcome: A systematic review and meta-analysis. Papers, record 36927176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36927176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stroke | Major topic |
| Humans | |
| Blood-Brain Barrier | |
| Tomography, X-Ray Computed | |
| Brain | |
| Permeability |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967054 | Beyond Blood-Brain Barrier Crossing in Reperfusion-Era Ischemic Stroke: Interface-Matched Active-Entity Delivery and Translational Product Design. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42967054 | PubMed |
| 42571485 | Defining biomaterial-driven design principles for bioabsorbable flow diverters: current state and perspectives. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42571485 | PubMed |
| 42565565 | [Factors influencing hemorrhagic transformation after mechanical thrombectomy in patients with acute ischemic stroke patients]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42565565 | PubMed |
| 42383029 | Quantifying cerebral autoregulation following endovascular thrombectomy using wavelet transformation. | Front Neurol | 2026 | https://conductscience.org/library/papers/42383029 | PubMed |
| 42100815 | Redefining the Cerebral Ischemic Core-Penumbra-Oligemia Continuum. | Stroke | 2026 | https://conductscience.org/library/papers/42100815 | PubMed |
| 41938171 | Blood-Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41938171 | PubMed |
| 41404729 | Blood-Brain Barrier Permeability Dynamics and Mediation of Triglyceride-Glucose Index on Acute Ischemic Stroke Outcomes. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41404729 | PubMed |
| 41398232 | Elevated circulation postsynaptic density protein 95 as a potential biomarker for predicting the diagnosis and prognosis of acute cerebral infarction. | BMC Neurol | 2025 | https://conductscience.org/library/papers/41398232 | PubMed |
| 41392086 | Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trial. | Nat Commun | 2025 | https://conductscience.org/library/papers/41392086 | PubMed |
| 41296416 | Key Components of PPEO in Antagonizing Cerebral Ischemic Reperfusion Injury in Rats by Regulating Ferroptosis Through Arachidonic Acid Metabolic Pathway. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41296416 | PubMed |
| 41017817 | The Immunologic Underpinnings of Post-Stroke Depression. | Biol Psychiatry Glob Open Sci | 2025 | https://conductscience.org/library/papers/41017817 | PubMed |
| 40722349 | Targeting CX3CR1 Signaling Dynamics: A Critical Determinant in the Temporal Regulation of Post-Stroke Neurorepair. | Brain Sci | 2025 | https://conductscience.org/library/papers/40722349 | PubMed |
| 40671921 | Recent progress on nanotechnologies for enhancing blood-brain barrier permeability. | Smart Mol | 2025 | https://conductscience.org/library/papers/40671921 | PubMed |
| 40640916 | Restoring brain barriers: an innovative approach for treating neurological disorders. | Fluids Barriers CNS | 2025 | https://conductscience.org/library/papers/40640916 | PubMed |
| 40510208 | Quantitative contrast enhancement volume on immediate post-thrombectomy CT predicts symptomatic intracranial hemorrhage and functional outcomes in acute large vessel occlusion stroke. | Front Neurol | 2025 | https://conductscience.org/library/papers/40510208 | PubMed |
| 40011926 | The blood-brain barriers: novel nanocarriers for central nervous system diseases. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40011926 | PubMed |
| 39807188 | 5-(3-(N-(Carboxymethyl)naphthalene-2-sulfonamido)phenyl)-1-ethyl-1H-pyrrole-2-carboxylic acid as a Keap1-Nrf2 inhibitor for cerebral ischemia/reperfusion injury treatment. | RSC Adv | 2025 | https://conductscience.org/library/papers/39807188 | PubMed |
| 39762518 | GYY4137 ameliorates blood brain barrier damage by inhibiting autophagy mediated occludin degradation in cardiac arrest and resuscitation. | Sci Rep | 2025 | https://conductscience.org/library/papers/39762518 | PubMed |
| 39211291 | Curcumin loaded hydrogel with double ROS-scavenging effect regulates microglia polarization to promote poststroke rehabilitation. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39211291 | PubMed |
| 38803916 | Quercetin improves the protection of hydroxysafflor yellow a against cerebral ischemic injury by modulating of blood-brain barrier and src-p-gp-mmp-9 signalling. | Heliyon | 2024 | https://conductscience.org/library/papers/38803916 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36927176
GET https://conductscience.org/api/papers/v1/36927176/cited_by?page=2